722. Risk Factors for Infection or Colonization with Ceftolozane/Tazobactam Non-Susceptible Extensively β-Lactam Resistant Pseudomonas aeruginosa

BACKGROUND: Treatment of infections due to multidrug resistant (MDR) Pseudomonas aeruginosa is complicated by co-resistance amongst traditional anti-pseudomonal β-lactams, as 50% of MDR isolates exhibit extensive β-lactam resistance (EBR, non-susceptible to cefepime, ceftazidime, piperacillin/tazoba...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Michelle, Nagel, Jerod, Wangchinda, Walaiporn, Pierce, Virginia M, Smith, Aaron, Bishop, Olivia, Pogue, Jason M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Abstract
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10678751/
http://dx.doi.org/10.1093/ofid/ofad500.783

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10678751/
http://dx.doi.org/10.1093/ofid/ofad500.783

Ejemplares similares